Form 4: Chemed Corp Executive Exercises Stock Options and Sells Shares

Michael D. Witzeman, VP & Chief Financial Officer of Chemed Corp, exercised stock options and sold shares to cover the purchase price and tax obligations.

Summary

• On March 10, 2025, Michael D. Witzeman, VP & Chief Financial Officer of Chemed Corp, exercised stock options to acquire 8,796 shares of Capital Stock at a price of $445.35.
• Simultaneously, Witzeman sold 7,494 shares of Capital Stock at $600.92 to cover the purchase price and tax obligations related to the option exercise.
• Following these transactions, Witzeman directly owns 5,660 shares of Chemed Corp Capital Stock and 34,484 Stock Options.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves the exercise of existing stock options and a small sale of shares in the open market.

Key Dates